Priebe Waldemar 4
4 · Moleculin Biotech, Inc. · Filed Aug 18, 2017
Insider Transaction Report
Form 4
Priebe Waldemar
10% Owner
Transactions
- Sale
Common Stock
2017-08-16$1.70/sh−100,000$170,300→ 2,781,573 total
Footnotes (2)
- [F1]The reporting person entered into a private sale agreement for the shares of common stock set forth in the table.
- [F2]In addition to the shares held directly by the reporting person, The reporting person is a shareholder and control person of IntertechBio Corp. IntertechBio Corp. holds 630,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp. The reporting person is also a shareholder and control person of Houston Pharmaceuticals, Inc. Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc.